Titan Pharmaceuticals Inc (TTNP)

[chantillylive]

Braeburn...

Enjoy.

cl.

Behshad Sheldon

President and CEO

Behshad Sheldon has more than 25 years of experience leading pharmaceutical development and commercialization in the United States and globally. Prior to joining Braeburn, Behshad spent 10 years at Otsuka Pharmaceuticals, having co-founded the Otsuka Princeton office in 2002. Ms. Sheldon last served as a member of the board of directors of the Otsuka R&D organization, contributing to the oversight of 18 pre-approval programs for 13 products in CNS, cardio-renal, pain, dermatology, and oncology. Simultaneously, she served as senior vice president, patient & branding strategy in the commercial organization, where she was responsible for global and United States marketing, alliance management, and early development strategy. Prior to Otsuka, Behshad held positions with increasing responsibility at SmithKline Beecham and Bristol-Myers Squibb. Throughout her 27-year career, Behshad has driven the success of blockbuster products such as Glucophage, Plavix, and Abilify, and has contributed to several strategic alliances and acquisitions, including the landmark 2011 agreement between Otsuka and Lundbeck involving 5 CNS products. Behshad holds a BS degree in Neuroscience from the University of Rochester.